BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30029837)

  • 21. Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI.
    Zhang XY; Wang L; Zhu HT; Li ZW; Ye M; Li XT; Shi YJ; Zhu HC; Sun YS
    Radiology; 2020 Jul; 296(1):56-64. PubMed ID: 32315264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Yu J; Xu Q; Song JC; Li Y; Dai X; Huang DY; Zhang L; Li Y; Shi HB
    Eur Radiol; 2017 May; 27(5):1848-1857. PubMed ID: 27631106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Bates DDB; Mazaheri Y; Lobaugh S; Golia Pernicka JS; Paroder V; Shia J; Zheng J; Capanu M; Petkovska I; Gollub MJ
    Abdom Radiol (NY); 2019 Nov; 44(11):3701-3708. PubMed ID: 31154482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DCE-MRI time-intensity curve visual inspection to assess pathological response after neoadjuvant therapy in locally advanced rectal cancer.
    Petrillo A; Fusco R; Petrillo M; Granata V; Bianco F; Di Marzo M; Delrio P; Tatangelo F; Botti G; Pecori B; Avallone A
    Jpn J Radiol; 2018 Oct; 36(10):611-621. PubMed ID: 30039258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer.
    Seierstad T; Hole KH; Grøholt KK; Dueland S; Ree AH; Flatmark K; Redalen KR
    Br J Radiol; 2015 Jul; 88(1051):20150097. PubMed ID: 25899892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Tong T; Sun Y; Gollub MJ; Peng W; Cai S; Zhang Z; Gu Y
    J Magn Reson Imaging; 2015 Sep; 42(3):673-80. PubMed ID: 25652254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
    Aker M; Ganeshan B; Afaq A; Wan S; Groves AM; Arulampalam T
    Dis Colon Rectum; 2019 Feb; 62(2):163-170. PubMed ID: 30451764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer.
    Gollub MJ; Tong T; Weiser M; Zheng J; Gonen M; Zakian KL
    Eur Radiol; 2017 Apr; 27(4):1605-1612. PubMed ID: 27436029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete Response Evaluation of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy Using Textural Features Obtained from T2 Weighted Imaging and ADC Maps.
    Azamat S; Karaman Ş; Azamat IF; Ertaş G; Kulle CB; Keskin M; Sakin RND; Bakır B; Oral EN; Kartal MG
    Curr Med Imaging; 2022; 18(10):1061-1069. PubMed ID: 35240976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.
    Hötker AM; Tarlinton L; Mazaheri Y; Woo KM; Gönen M; Saltz LB; Goodman KA; Garcia-Aguilar J; Gollub MJ
    Eur Radiol; 2016 Dec; 26(12):4303-4312. PubMed ID: 26945761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation.
    Intven M; Reerink O; Philippens ME
    J Magn Reson Imaging; 2015 Jun; 41(6):1646-53. PubMed ID: 25124320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR Imaging with Apparent Diffusion Coefficient Histogram Analysis: Evaluation of Locally Advanced Rectal Cancer after Chemotherapy and Radiation Therapy.
    Enkhbaatar NE; Inoue S; Yamamuro H; Kawada S; Miyaoka M; Nakamura N; Sadahiro S; Imai Y
    Radiology; 2018 Jul; 288(1):129-137. PubMed ID: 29558294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Could early tumour volume changes assessed on morphological MRI predict the response to chemoradiation therapy in locally-advanced rectal cancer?
    Palmisano A; Esposito A; Di Chiara A; Ambrosi A; Passoni P; Slim N; Fiorino C; Albarello L; Di Muzio N; Calandrino R; Rosati R; Del Maschio A; De Cobelli F
    Clin Radiol; 2018 Jun; 73(6):555-563. PubMed ID: 29459138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion kurtosis imaging-derived histogram metrics for prediction of resistance to neoadjuvant chemoradiotherapy in rectal adenocarcinoma: Preliminary findings.
    Li D; Cui Y; Hou L; Bian Z; Yang Z; Xu R; Jia Y; Wu Z; Yang X
    Eur J Radiol; 2021 Nov; 144():109963. PubMed ID: 34562744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
    Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
    Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer.
    Kluza E; Rozeboom ED; Maas M; Martens M; Lambregts DM; Slenter J; Beets GL; Beets-Tan RG
    Eur Radiol; 2013 Jan; 23(1):253-61. PubMed ID: 22777621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.
    Xu L; Ge X; Sun N; Liu X
    Acta Radiol; 2020 Oct; 61(10):1316-1325. PubMed ID: 32053003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience.
    Nougaret S; Fujii S; Addley HC; Bibeau F; Pandey H; Mikhael H; Reinhold C; Azria D; Rouanet P; Gallix B
    J Magn Reson Imaging; 2013 Sep; 38(3):726-32. PubMed ID: 23152299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival.
    Bakke KM; Hole KH; Dueland S; Grøholt KK; Flatmark K; Ree AH; Seierstad T; Redalen KR
    Acta Oncol; 2017 Jun; 56(6):813-818. PubMed ID: 28464745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.